You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Ret Proto-Oncogene (RET) Antibodies

Full name:
anti-Ret Proto-Oncogene Antibodies (RET)
On are 361 Ret Proto-Oncogene (RET) Antibodies from 23 different suppliers available. Additionally we are shipping Ret Proto-Oncogene Proteins (31) and Ret Proto-Oncogene Kits (14) and many more products for this protein. A total of 426 Ret Proto-Oncogene products are currently listed.
c-Ret, CDHF12, CDHR16, cret, etID315074.13, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET, ret-A, RET-ELE1, ret1, RET9, RET51, wu:fd13h01, X-ret, xret
list all antibodies Gene Name GeneID UniProt
RET 5979 P07949
RET 19713 P35546
RET 24716  

Show all species

Show all synonyms

Most Popular Reactivities for anti-Ret Proto-Oncogene (RET) Antibodies

Select your species and application

anti-Human Ret Proto-Oncogene Antibodies:

anti-Mouse (Murine) Ret Proto-Oncogene Antibodies:

anti-Rat (Rattus) Ret Proto-Oncogene Antibodies:

All available anti-Ret Proto-Oncogene Antibodies

Go to our pre-filtered search.

Top referenced anti-Ret Proto-Oncogene Antibodies

  1. Human Polyclonal Ret Proto-Oncogene Primary Antibody for WB - ABIN1882126 : Siqueira, Romitti, da Rocha, Ceolin, Meotti, Estivalet, Puñales, Maia: The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma. in Endocrine-related cancer 2010 (PubMed)
    Show all 4 references for ABIN1882126

  2. Human Polyclonal Ret Proto-Oncogene Primary Antibody for EIA, FACS - ABIN359926 : Da Silva, Maciel, Da Silva, Toledo, De Carvalho, Cerutti: A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. in The Journal of clinical endocrinology and metabolism 2003 (PubMed)
    Show all 4 references for ABIN359926

  3. Human Monoclonal Ret Proto-Oncogene Primary Antibody for IHC (p) - ABIN115113 : Nosrat, Tomac, Hoffer, Olson: Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. in Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1997 (PubMed)
    Show all 3 references for ABIN115113

  4. Human Monoclonal Ret Proto-Oncogene Primary Antibody for IF, IHC (p) - ABIN659065 : Gockel, Schumacher, Gockel, Lang, Haaf, Nöthen: Achalasia: will genetic studies provide insights? in Human genetics 2010 (PubMed)
    Show all 3 references for ABIN659065

  5. Human Polyclonal Ret Proto-Oncogene Primary Antibody for IF, IHC - ABIN1450578 : Takahashi, Buma, Hiai: Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. in Oncogene 1989 (PubMed)
    Show all 2 references for ABIN1450578

  6. Human Polyclonal Ret Proto-Oncogene Primary Antibody for ELISA, WB - ABIN1531387 : Takahashi, Buma, Iwamoto, Inaguma, Ikeda, Hiai: Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. in Oncogene 1990 (PubMed)
    Show all 2 references for ABIN1531387

  7. Human Monoclonal Ret Proto-Oncogene Primary Antibody for ELISA, WB - ABIN1724684 : Young, Anderson, Anderson: Guidance cues involved in the development of the peripheral autonomic nervous system. in Autonomic neuroscience : basic & clinical 2004 (PubMed)
    Show all 2 references for ABIN1724684

  8. Human Polyclonal Ret Proto-Oncogene Primary Antibody for IHC (p), WB - ABIN392038 : Takaki, Nakayama, Misawa, Nakagawa, Kuniyasu: In vitro formation of enteric neural network structure in a gut-like organ differentiated from mouse embryonic stem cells. in Stem cells (Dayton, Ohio) 2006 (PubMed)

  9. Human Polyclonal Ret Proto-Oncogene Primary Antibody for IHC (p), WB - ABIN392041 : de Martimprey, Bertrand, Fusco, Santoro, Couvreur, Vauthier, Malvy: siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. in Nucleic acids research 2008 (PubMed)

More Antibodies against Ret Proto-Oncogene Interaction Partners

Zebrafish Ret Proto-Oncogene (RET) interaction partners

  1. RET expression is investigated within the brain of zebrafish; both RET protein and mRNA are observed.

  2. In animals lacking Ret or Gfra3 (show GFRA3 Antibodies) function, myogenic gene expression is reduced in forming opercular muscles, but not in non-opercular muscles derived from the same muscle anlagen.

  3. evaluation of noncoding sequences at the zebrafish ret locus conserved among teleosts, and at the human RET locus, conserved among mammals

  4. genes beyond RET may be implicated in the genesis of sporadic cases of HD

Human Ret Proto-Oncogene (RET) interaction partners

  1. Study shows that the RET nuclear expression was an independent predictor of renal clear cell carcinoma postoperative metastasis.

  2. neither RAS mutation nor RET rearrangements were found to be associated with the clinicopathological characteristics of papillary thyroid cancer

  3. RET gene rearrangement is associated with Lung Cancer.

  4. Our results further substantiate that most germline mutations of the RET proto-oncogene were localized at codon 634 in Chinese hereditary medullary thyroid carcinoma patients and carriers

  5. MEN-PCC from India, the commonest causative RET mutations for MEN-PCC involved codon 634. MEN-PCC patients were younger, and more frequently had bilateral PCC than non-MEN disease.

  6. Study reports the coexistence of a germline intronic heterozygote variation at the MEN1 (show MEN1 Antibodies) gene (IVS4+1G>T) and a germline mutation of exon 11 of RET proto-oncogene (K666M) in a large Italian family and describes clinical manifestations in the carriers.

  7. the RET p.S891A mutation combined with OSMR (show OSMR Antibodies) p.G513D may underlie a novel phenotype manifesting as familial medullary thyroid carcinoma and cutaneous amyloidosis

  8. Presence of a RET fusion kinase may identify a subset of metastatic colorectal cancer patients with a high response rate to RET kinase inhibition.

  9. Lung adenocarcinomas with RET and ROS1 fusions share many radiographic features.

  10. the frequency profile of RET mutations in the Azari population of Iran with Medullary thyroid carcinoma (MTC (show MT1A Antibodies)) is 61.7%.

Mouse (Murine) Ret Proto-Oncogene (RET) interaction partners

  1. Ret and Gfra2 (show GFRA2 Antibodies) null mice display comparable early central projection deficits, but Gfra2 (show GFRA2 Antibodies) null rapidly adapting mechanoreceptors recover later.

  2. Parkin (show PARK2 Antibodies) and the RET signaling cascade converge to control mitochondrial integrity and thereby properly maintain substantia nigra pars (show EPRS Antibodies) compacta dopaminergic neurons and their innervation in the striatum.

  3. the Ret signaling pathway is important for podocyte survival and recovery from glomerular injury in vivo

  4. RET coupling to ERK (show EPHB2 Antibodies) and Akt (show AKT1 Antibodies) depends strongly on artemin (show ARTN Antibodies) concentration, and it is highest at the low (~100 pM) artemin (show ARTN Antibodies) levels required for neurite outgrowth.

  5. we analysed non-thermal, atmospheric pressure, plasma irradiation mediated effects in melanocytic tumors which spontaneously developed in HL-RET-mice

  6. the important IL-10 (show IL10 Antibodies) transcription factor Maf (show MAF Antibodies) was upregulated in RET-deficient Th2 cells and down-regulated upon RET signalling activation by glial-derived neurotrophic factor (show NTF3 Antibodies) family ligands.

  7. the neurotrophic factor (show NTF3 Antibodies) receptor RET drives haematopoietic stem cell survival, expansion and function; haematopoietic stem cells express RET and its neurotrophic factor (show NTF3 Antibodies) partners are produced in the haematopoietic stem cell environment

  8. TNFR1 (show TNFRSF1A Antibodies) exerts a dual role in nociceptor information processing by suppressing TrkA (show NTRK1 Antibodies) and enhancing Ret signaling in peptidergic and nonpeptidergic nociceptors, respectively.

  9. only the SH3 domains of CD2AP (show Cd2ap Antibodies) are necessary to enhance the E3 ligase activity of Cbl-3 (show CBLC Antibodies)/c toward Ret51

  10. These data establish mTOR (show FRAP1 Antibodies) as a key mediator of RET-mediated cell growth in thyroid cancer cells and provide a rationale for combinatorial treatments in thyroid cancers with oncogenic RET mutations.

Ret Proto-Oncogene (RET) Antigen Profile

Antigen Summary

This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed.

Alternative names and synonyms associated with Ret Proto-Oncogene (RET)

  • ret proto-oncogene receptor tyrosine kinase (ret) antibody
  • ret proto-oncogene (ret) antibody
  • ret proto-oncogene (RET) antibody
  • ret proto-oncogene (Ret) antibody
  • c-Ret antibody
  • CDHF12 antibody
  • CDHR16 antibody
  • cret antibody
  • etID315074.13 antibody
  • HSCR1 antibody
  • MEN2A antibody
  • MEN2B antibody
  • MTC1 antibody
  • PTC antibody
  • RET antibody
  • ret-A antibody
  • RET-ELE1 antibody
  • ret1 antibody
  • RET9 antibody
  • RET51 antibody
  • wu:fd13h01 antibody
  • X-ret antibody
  • xret antibody

Protein level used designations for RET

proto-oncogene tyrosine-protein kinase receptor Ret , receptor tyrosine kinase , ret proto-oncogene , tryptase , proto-oncogene tyrosine-protein kinase receptor Ret-like , RET transforming sequence , cadherin family member 12 , cadherin-related family member 16 , hydroxyaryl-protein kinase , proto-oncogene c-Ret , ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) , Ret gene for receptor tyrosin , Ret proto-oncogene (multiple endocrine neoplasia MEN2A MEN2B and medullary thyroid carcinoma 1 Hirschsprung disease) , ret tyrosine kinase

30512 Danio rerio
373625 Xenopus laevis
449594 Pan troglodytes
703466 Macaca mulatta
100033966 Equus caballus
100403596 Callithrix jacchus
100442682 Pongo abelii
100467317 Ailuropoda melanoleuca
100495902 Xenopus (Silurana) tropicalis
100602103 Nomascus leucogenys
5979 Homo sapiens
19713 Mus musculus
24716 Rattus norvegicus
403494 Canis lupus familiaris
396107 Gallus gallus
515924 Bos taurus
100340710 Oryctolagus cuniculus
100733392 Cavia porcellus
Selected quality suppliers for anti-Ret Proto-Oncogene (RET) Antibodies
Did you look for something else?